Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Abstract Background Recent advancements in immunotherapy, particularly pembrolizumab, have shown promising results in treating metastatic colorectal cancer (CRC) and triple-negative breast cancer (TNBC). Accurate detection of predictive biomarkers, such as microsatellite instability (MSI)/mismatch r...
Saved in:
| Main Authors: | Yating Cheng, Norsang Lama, Ming Chen, Eghbal Amidi, Mohammadreza Ramzanpour, Md Ashequr Rahman, Joanne Xiu, Anthony Helmstetter, Lauren Dickman, Jennifer R. Ribeiro, Hassan Ghani, Matthew Oberley, David Spetzler, George W. Sledge |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-01045-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach
by: Eghbal Amidi, et al.
Published: (2025-07-01) -
Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer
by: Eduardo Feliciangeli, et al.
Published: (2025-07-01) -
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis
by: George W. Jr. Sledge, et al.
Published: (2025-08-01) -
HER2-IHC-40x: A high-resolution histopathology dataset for HER2 IHC scoring in breast cancerZenodo
by: Md Serajun Nabi, et al.
Published: (2025-10-01) -
H&E to IHC virtual staining methods in breast cancer: an overview and benchmarking
by: Pascal Klöckner, et al.
Published: (2025-07-01)